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Abstract 
Recent  advances  in  supportive  care  and
progress  in  the  development  and  use  of
chemotherapy have considerably improved the
prognosis of many children with malignancy,
thus the need for intensive care admission and
management  is  increasing,  reaching  about
40% of patients throughout the disease course.
Cancer remains a major death cause in chil-
dren,  though  outcomes  have  considerably
improved over the past decades. Prediction of
outcome for children with cancer in Pediatric
Intensive Care Unit (PICU) obviously requires
clinical  guidelines,  and  these  are  not  well
defined, as well as admission criteria. Major
determinants  of  negative  outcomes  remain
severe sepsis/septic shock association and res-
piratory failure, deserving specific approach in
children with cancer, particularly those receiv-
ing  a bone marrow transplantation. A nation-
wide  consensus  should  be  achieved  among
pediatric intensivists and oncologists regard-
ing the threshold clinical conditions requiring
Intensive Care Unit (ICU) admission as well
as specific critical care protocols. As demon-
strated for the critically ill non-oncologic child,
it appears unreasonable that pediatric patients
with malignancy can be admitted to an adult
Intensive Care Unit ICU. On a national basis a
pool of refecence institutions should be identi-
fied and early referral to an oncologic  PICU is
warranted. 
Introduction
Cancer remains a major death cause in chil-
dren,  though  outcomes  have  considerably
improved over the past decades.1-3 Outcomes
for  children  diagnosed  with  cancer  have
changed since ’70 from 80% mortality to 80%
survival;2 while children with solid tumors 5-
year survival has been reported as 67%, cure
rates  for  childhood  leukemia  now  approach
90%.4,5 Moreover,  hematopoietic  stem  cell
transplantation  (HSCT)  indications  are  still
expanding for both malignant and non-malig-
nant diseases. 
Some of the improvement in survival has
been linked to more aggressive cancer treat-
ment regimens. However, these protocols are
associated with an increase in complications
and life-threatening events that may require
PICU  admission.  As  a  consequence,  cancer
therapy  advances  have  resulted  in  an
increased  need  for  critical  care  services  for
these children. Intensive care itself can cause
unavoidalble  complications,  the  most  promi-
nent of which are infections that result from
treatment-associated  immunosuppression.
Eventually,  nearly  40%  of  pediatric  cancer
patients  require  intensive  care  services,
accounting for approximately 3% of all PICU
admissions.6,7
Recently, a 3-year (2003-2005) nationwide
italian  (involving  27  institutions)  survey,
regarding the outcomes of cancer children out-
lined respiratory failure and severe sepsis/sep-
tic shock as major risk factors for cancer-relat-
ed  ICU  mortality  (M.Piastra,  unpublished
data). Globally, 1367 patients were enrolled, of
whom  464  medical  (non-postoperative)
patiens; PICU survival was about 71.5%, with
substantial differences among different criti-
cal illnesses. Before these data become avail-
able, national survival rates for PICU cancer
patients were not known. In the past decades
reported  survival  rates  ranged  from  almost
100% mortality in patients requiring prolonged
mechanical  ventilation  to  100%  survival  in
those  receiving  uncomplicated  postoperative
care; therefore, concerns arose regarding the
futility of treating critically ill cancer patients.8-11
In fact, the few published studies on the out-
come of children with malignancies who were
admitted  to  PICU  reported  poor  outcomes,
especially for those requiring ventilatory sup-
port or inotropic support in the context of sep-
sis  or  after  bone  marrow  transplant.12,13
Nevertheless, recent studies have demonstrat-
ed promising outcomes with an overall survival
rate  of  >80%  in  paediatric  cancer  patients
admitted  to  a  PICU.6,14 Furthermore,  great
efforts have been undertaken to assess the risk
of mortality and outcome in paediatric cancer
patients.15
Taking into consideration recent italian epi-
demiological data, an effort has been under-
taken in order to develop and disclose PICU
admission criteria for onco-hematological chil-
dren. Based on main causes, baseline sugges-
tions are being offered aimed at early referral
of  critically  ill  patients  affected  by  systemic
infections and respiratory failure.
Severe sepsis/septic shock
patients
For severe sepsis-septic shock the observed
mortality remains still high, and consistently
higher than recently reported for the italian
non-oncologic  pediatric  population:  namely
55% in the above mentioned italian survey.16
International  sepsis  guidelines  advocate  a
timely  approach  to  cardiovascular  derange-
ments in septic patients, involving early moni-
toring of hemodynamic status for patients with
fluid-refractory shock. Self-reported data evi-
denced that advanced continuous hemodynam-
ic monitoring has been reported by a minority
of institutions in the 2003-2005 survey. A lim-
ited use of invasive monitoring in children and
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infants should not be longer accepted, given
the possibility of accurate and safer echo-guid-
ed  techniques  even  in  younger  infants.17
According to recent international guidelines,18
hemodynamic  monitoring  should  guide  the
management of critically ill children very early
after ICU admission: the rapid identification of
the hemodynamic pattern and – as a conse-
quence -preload/vasoactive combination thera-
py tailoring can really influence the mortality
from sepsis also in cancer children. 
The timely identification of sepsis towards
severe sepsis-septic shock shift and the early
ICU referral of these patients is of mainstem
importance. The widespread use of vasoactive
agents outside an ICU setting should be dis-
couraged,  lacking  appropriate  hemodynamic
monitoring; conversely, educational programs
should  be  implemented  in  order  to  improve
early circulatory status diagnosis. Both nonin-
vasive  Doppler  devices  and  bedside  basic
echocardiography can be introduced,  having
an acceptable learning curve - thereby increas-
ing diagnostic accuracy yet in the non-inten-
sive setting.
PICU referral of severely hypotensive (late
referral)  patients  should  be  prevented;
patients with unexplained tachycardia (having
ruled out fever and agitation) and early dias-
tolic blood pressure decrease or signs of hypop-
erfusion (including increasing negative Base
Excess or hyperlactacidemia) are more likely
to benefit from PICU admission (Table 1).
Acute respiratory failure 
A recent review paper on pediatric oncology
patients  requiring  conventional  respiratory
support  outlined  current  outcomes  both  in
Bone Marrow Transplantation (BMT) and non-
BMT  children,19 while  encouraging  clinical
research regarding both NIV and new inter-
faces suitable for pediatric use, Long-term sur-
vival after even prolonged mechanical ventila-
tion in PICU has  been reported. Very recently,
an italian pediatric experience20 seems to con-
firm  the  role  of  NPPV  in  immunocompro-
mised/cancer children affected by early Acute
Respiratory Ditress Syndrome (ARDS), as yet
demonstrated and well established in adults.21-
24 In this feasibility study we reported that 56%
of immunocompromised children with ARDS,
deemed to require conventional invasive venti-
lation,  could  be  successfully  managed  with
Non  invasive  Positive  Pressure  Ventilation
(NPPV),  avoiding endotracheal intubation and
possibly related complications.20 Children suc-
cessfully ventilated with NPPV also showed a
shorter PICU and hospital stay, a lower inci-
dence  of    septic  complications,  including
Ventilator  Associated  Pneumonia  (VAP)  and
septic  shock.  Notably,  at  PICU  admission
severity scores and organ failures did not differ
between the NPPV-success and failure groups.
As a whole, these data strongly suggest that a
NPPV trial should be considered in immuno-
compromised children with early Acute Lung
Injury (ALI) and ARDS. 
Moreover,  recent  data  from  a  randomized
trial seems to sustain an even earlier introduc-
tion of noninvasive ventilatory support. In his
paper, VM Ranieri and his coworkers highlinght
the importance of very early Continous Positive
Airway  Pressure  (CPAP)  introduction:  this
study demonstrates that early use of CPAP in
the hematological ward in immunosuppressed
patients  with  hematological  malignancy,  but
without  a  secure  diagnosis  of  infection,  may
prevent  evolution  of  respiratory  symptoms  to
acute lung injury requiring ventilatory support
and ICU admission.25These experiences should
be confirmed even in childhood, but it seems
that  a similar rationale exists.  Based on these
data and the available scientific evidence, an
erlier  CPAP  introduction  in  respiratory  dis-
tressed  patients  should  be  encouraged,  com-
pared to previous recommendations. The intro-
duction of CPAP within the pediatric oncology
setting  represents  an  interesting  option  that
can be performed provided that i) a continuous
gas exchange monitoring can be guaranteed; ii)
both medical and non-medical caregivers have
been specifically trained iii) a regular supervi-
sion and timely intervention by pediatric ICU
team  can  be  offered.  Previously,    respiratory
parameters threshold had been identifyied for
PICU referral (or respiratory support introduc-
tion, depending on the setting): the association
of SatO2 ≥92% while on 0.30 FiO2 has been sug-
gested.  By  the    light  of  recent  evidences,  it
seems that every respiratory change (in associ-
ation  with  chest  film  alterations)  including
Respiratory Rate increase by 30% and SatO2
<92% on room air should be investigated and
early  CPAP  implementation  considered.  We
actually agree with such a more interventional
attitude, thus we will increasingly offer CPAP
for hypoxaemic H&O patients  than simple oxy-
gen support  in the future.
Pediatric oncology intensive
care specificity
As  recently  demonstrated,  intensive  care
outcomes can be very different outside a pedi-
atric-devoted ICU:  in fact, a suboptimal out-
come of children in general adult ICUs in Italy
is suggested by this analysis.26 Interestingly,
the time frame is overlapping with our epi-
demiological  study  (2003-2005),  involving
patients from 27 italian ICUs (21 PICUs and 6
general ICUs) . As a general rule, some reluc-
tance or unjustified delay in treating pediatric
oncology critically ill patients can be present in
general ICUs. Again, a strong rationale  sup-
porting the centralisation of critically ill chil-
dren to PICUs exist, particurlarly in the setting
of  pediatric  oncology.  In  fact,  early
invasive/noninvasive hemodynamic and venti-
latory support may really impact on the out-
come of the cancer pediatric patient.  Patients
should be rapidly referred – based on pediatric
intensivist’s opinion- from areas lacking spe-
cialised  pediatric  intensive  care.  Recent
advances in pediatric oncology clearly require
a high-level critical care as a part of the thera-
peutic program. Therefore, a network of spe-
cialised  oncology  critical  care  institutions
should be identifyied on a national basis.
Case Report
Table 1. Organ failure signs triggering Intensive Care Unit  team assessment and possi-
bly Intensive Care Unit  admission/treatment in H&O pediatric patient.
Organ/System Failure PICU admission parameters
Respiratory failure 30% increase basal RR, SatO2 < NIV introduction also in
92% on room air, CXR and clinical signs extra-intensive
setting (subintensive, 
respiratory unit)
Severe sepsis  Haemodynamic compromise signs according to age: threshold values
Diastolic BP Systolic BP Heart Rate   
Infant 53 mmHg 72 mmHg 180
Preschool 53 mmHg 7 mmHg 160
School 57  mmHg 83 mmHg 140
Adolescent 66  mmHg 90 mmHg 125
Neurologic compromise GCS <12  or > 3 points variation from baseline; relapsing seizures
Kidney failure Fluid overload, oliguria,  electrolyte derangements, CRRT (all)
Liver failure Severe hypocoagulability, liver support, hepatic enkephalopathy
BP, blood pressure; CRRT,  continuous renal replacement therapy; CXR, chest X-rays; GCS, glasgow coma scale; NIV, non invasive ventilation;
RR, respiratory rate[page 44] [Pediatric Reports 2011; 3:e13]
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